Search Results
Showing 3 of 3 results
What are Biologics and Biosimilars
We explain the difference between biologics and biosimilars and showcase Teva s innovative work in this space
Our goal is to lead the field of biosimilars just like we lead in generic medicines
Dr Nir Shapir VP of Teva s global research and development team and CMC Biosimilars division discusses Teva s entry into the biosimilars market and the complexity of manufacturing biopharmaceuticals Read the interview with Haaretz reprinted with permission
Biosimilar Medicine Has Made a Difference to My Life
Rachna Sood Project Manager Employee Experience with Teva UK was diagnosed with the autoimmune condition lupus more than 20 years ago She talks about the important medicines that help her to manage her condition
